Laura Cosmai Selected Research

Laura Cosmai Research Topics

Disease

19	Neoplasms (Cancer) 05/2022 - 06/2015
11	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 09/2012
7	Kidney Neoplasms (Kidney Cancer) 10/2021 - 09/2012
5	Chronic Renal Insufficiency 09/2020 - 01/2016
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 09/2012
3	Renal Insufficiency (Renal Failure) 12/2020 - 04/2018
2	Carcinoma (Carcinomatosis) 06/2022 - 01/2021
2	Obesity 01/2021 - 07/2008
2	Acute Kidney Injury (Acute Renal Failure) 04/2016 - 01/2016
1	Body Weight (Weight, Body) 05/2022
1	Overweight 01/2021
1	Multiple Myeloma 01/2021
1	Vascular Calcification 01/2021
1	Ciliopathies 12/2020
1	Vitamin K Deficiency 09/2020
1	Bone Fractures (Bone Fracture) 09/2020
1	Brain Neoplasms (Brain Tumor) 12/2018
1	Sepsis (Septicemia) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Tumor Lysis Syndrome 04/2016
1	Kidney Diseases (Kidney Disease) 01/2016
1	Autosomal Dominant Polycystic Kidney (ADPKD) 12/2015
1	Cystic Kidney Diseases (Cystic Kidney Disease) 12/2015
1	Colonic Neoplasms (Colon Cancer) 12/2015
1	Cysts 12/2015
1	Tachycardia (Tachyarrhythmias) 07/2008
1	Hypertension (High Blood Pressure) 07/2008
1	Hyponatremia 07/2008
1	Heart Failure 07/2007
1	Myocardial Infarction 07/2007

Drug/Important Bio-Agent (IBA)

6	Antineoplastic Agents (Antineoplastics)IBA 12/2020 - 06/2015
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	Vitamin K FDA Link 01/2021 - 01/2018
2	pembrolizumabIBA 10/2021 - 10/2020
2	CytokinesIBA 10/2021 - 07/2007
2	Axitinib (AG 013736)IBA 10/2021 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2020
2	MTOR InhibitorsIBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 04/2017
2	Phosphotransferases (Kinase)IBA 04/2018 - 12/2015
2	Calcineurin InhibitorsIBA 04/2016 - 12/2015
1	erdafitinibIBA 06/2022
1	GadoliniumIBA 05/2022
1	Zoledronic Acid (Zometa)FDA Link 05/2022
1	Cisplatin (Platino)FDA LinkGeneric 05/2022
1	Interleukin-2 (IL2)IBA 10/2021
1	InterferonsIBA 10/2021
1	Amino Acids FDA Link 01/2021
1	ParaproteinsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Vitamin K 2 (Vitamin K2)IBA 01/2021
1	NivolumabIBA 10/2020
1	avelumabIBA 10/2020
1	Sunitinib (Sutent)FDA Link 10/2020
1	IpilimumabIBA 10/2020
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 09/2020
1	Biological ProductsIBA 08/2019
1	pazopanib FDA Link 02/2019
1	Angiogenesis InhibitorsIBA 04/2018
1	lenvatinibIBA 04/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2016
1	ElectrolytesIBA 04/2016
1	TOR Serine-Threonine KinasesIBA 12/2015
1	Tyrosine (L-Tyrosine)FDA Link 12/2015
1	Everolimus FDA Link 01/2015
1	Tyrosine Kinase InhibitorsIBA 09/2012
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2008
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 07/2008
1	sibutramine (Meridia)FDA Link 07/2008
1	Serotonin AgentsIBA 07/2008

Therapy/Procedure

9	Therapeutics 10/2021 - 07/2008
3	Immunotherapy 10/2021 - 10/2019
3	Kidney Transplantation 02/2019 - 01/2016
2	Renal Dialysis (Hemodialysis) 01/2021 - 08/2019
2	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2019 - 01/2016
2	Transplantation 04/2016 - 12/2015
1	Molecular Targeted Therapy 01/2019
1	Nephrectomy 12/2018
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Pain Management 01/2016